× Alert! To view the full data details, please Login or Register. Synopsis: VC SBIR-STTR Data Acquired Firms 2,869 (8.51%) Acquiring Entities 1,807 Transactions 2,951 M&A Deals Value $550.5B VC Funded Firms 1,350 Total VC Investment $56.2B Distribution of M&A transactions SBIR M&A Deals Value: non-VC & VC Funded Firms (last 10 years) SBIR M&A Num Deals: non-VC & VC Funded Firms (last 10 years) SBIR M&A Key Takeaways SBIR M&A by Price Paid: non-VC & VC Funded Firms Featured SBIR Firm Seattle Genetics Inc Only briefly SBIR-involved in the few years after the firm was founded but with some of the current principals having been with the start-up, Seattle Genetics is a now clinical-stage biotechnology company focused on developing and commercializing mon... see more www.seattlegenetics.com | (425) 527-4000 SBIR M&A & Partnering News Date Title Feb 27 2026 Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy Oct 30 2024 Opus Genetics acquired, becomes public company based in NC Apr 03 2024 Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement Nov 13 2023 Selecta Biosciences Announces Merger with Cartesian Therapeutics Aug 22 2023 Grander Closes Acquisition of PolarityTE, Inc. Assets Explanation ×
